Jennifer Ligibel, MD, breast medical oncologist and director of Dana-Farber's Leonard P. Zakim Center for Integrative Therapies and Healthy Living discusses exercise, weight loss, and breast cancer in the era of GLP1 medications at the 4th annual Ductal Carcinoma In Situ Patient Forum May 16, 2026. To learn more about the DCIS Program, visit us at https://www.dana-farber.org/cancer-care/treatment/breast-oncology/programs/ductal-carcinoma-in-situ To learn more about the Zakim center, visit https://www.dana-farber.org/patient-family/support-services/integrative-therapies

Understanding Chemo Neuropathy: A Webinar by the Older Adults with GI Cancer Program | Dana-Farber
19 views

Learning About Chronic Lymphocytic Leukemia | Lymph Notes: A Lymphoma Learning Series
112 views

ASCO26: David Reardon, MD Glioblastoma Vaccine | Dana-Farber Cancer Institute
106 views

Society of Gynaecological Oncology Congress 2026: Tara Berman, MD | Dana-Farber Cancer Institute
30 views

ASCO26: Julia Rotow, MD Silevertinib in Lung Cancer | Dana-Farber Cancer Institute
55 views

ASCO26: Atish Choudhury, MD, PhD A-DREAM/Alliance A032101 | Dana-Farber Cancer Institute
38 views